These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 32074448

  • 1. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J, Walker J, Ackermann R, Olsen K, Hong JKY, Wang Y, Schwendeman SP.
    Mol Pharm; 2020 May 04; 17(5):1502-1515. PubMed ID: 32074448
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres.
    Schutzman R, Shi NQ, Olsen KF, Ackermann R, Tang J, Liu YY, Hong JKY, Wang Y, Qin B, Schwendeman A, Schwendeman SP.
    J Control Release; 2023 Sep 04; 361():297-313. PubMed ID: 37343723
    [Abstract] [Full Text] [Related]

  • 5. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Schwendeman SP.
    Drug Deliv Transl Res; 2022 Mar 04; 12(3):695-707. PubMed ID: 34215997
    [Abstract] [Full Text] [Related]

  • 6. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release.
    Andhariya JV, Jog R, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ.
    J Control Release; 2019 Nov 28; 314():25-37. PubMed ID: 31654687
    [Abstract] [Full Text] [Related]

  • 7. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.
    Shi NQ, Zhou J, Walker J, Li L, Hong JKY, Olsen KF, Tang J, Ackermann R, Wang Y, Qin B, Schwendeman A, Schwendeman SP.
    J Control Release; 2020 May 10; 321():756-772. PubMed ID: 31935481
    [Abstract] [Full Text] [Related]

  • 8. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP.
    Mol Pharm; 2020 Nov 02; 17(11):4141-4151. PubMed ID: 32876463
    [Abstract] [Full Text] [Related]

  • 9. Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres.
    Liang D, Walker J, Schwendeman PS, Chandrashekar A, Ackermann R, Olsen KF, Beck-Broichsitter M, Schwendeman SP.
    Drug Deliv Transl Res; 2025 Jan 02; 15(1):185-202. PubMed ID: 38643259
    [Abstract] [Full Text] [Related]

  • 10. Influence of PLGA molecular weight distribution on leuprolide release from microspheres.
    Ochi M, Wan B, Bao Q, Burgess DJ.
    Int J Pharm; 2021 Apr 15; 599():120450. PubMed ID: 33675924
    [Abstract] [Full Text] [Related]

  • 11. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLGA microspheres.
    Wan B, Bao Q, Wang R, Burgess DJ.
    Int J Pharm; 2022 Sep 25; 625():122032. PubMed ID: 35878870
    [Abstract] [Full Text] [Related]

  • 12. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation.
    Chandrashekar A, Beig A, Wang Y, Schwendeman SP.
    Int J Pharm; 2023 Aug 25; 643():123213. PubMed ID: 37423376
    [Abstract] [Full Text] [Related]

  • 13. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.
    Beig A, Ackermann R, Wang Y, Schutzman R, Schwendeman SP.
    Int J Pharm; 2022 Aug 25; 624():121842. PubMed ID: 35609832
    [Abstract] [Full Text] [Related]

  • 14. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
    Liang D, Frank S, Schwendeman SP.
    Drug Deliv Transl Res; 2024 Mar 25; 14(3):696-704. PubMed ID: 38038895
    [Abstract] [Full Text] [Related]

  • 15. Effect of polymer source on in vitro drug release from PLGA microspheres.
    Wan B, Andhariya JV, Bao Q, Wang Y, Zou Y, Burgess DJ.
    Int J Pharm; 2021 Sep 25; 607():120907. PubMed ID: 34332059
    [Abstract] [Full Text] [Related]

  • 16. Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation.
    Hirota K, Doty AC, Ackermann R, Zhou J, Olsen KF, Feng MR, Wang Y, Choi S, Qu W, Schwendeman AS, Schwendeman SP.
    J Control Release; 2016 Dec 28; 244(Pt B):302-313. PubMed ID: 27565212
    [Abstract] [Full Text] [Related]

  • 17. Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review.
    Hua Y, Su Y, Zhang H, Liu N, Wang Z, Gao X, Gao J, Zheng A.
    Drug Deliv; 2021 Dec 28; 28(1):1342-1355. PubMed ID: 34180769
    [Abstract] [Full Text] [Related]

  • 18. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
    Wu C, Luo X, Baldursdottir SG, Yang M, Sun X, Mu H.
    Eur J Pharm Biopharm; 2019 Sep 28; 142():315-321. PubMed ID: 31299277
    [Abstract] [Full Text] [Related]

  • 19. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres.
    Li T, Chandrashekar A, Beig A, Walker J, Hong JKY, Benet A, Kang J, Ackermann R, Wang Y, Qin B, Schwendeman AS, Schwendeman SP.
    Eur J Pharm Biopharm; 2021 Jan 28; 158():401-409. PubMed ID: 33122118
    [Abstract] [Full Text] [Related]

  • 20. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P, Bu R, Zhang H, Yin J, Chen J, Zhang A, Gou J, Yin T, Zhang Y, He H, Wang P, Tang X, Wang Y.
    Mol Pharm; 2019 Aug 05; 16(8):3502-3513. PubMed ID: 31251642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.